GLP-1 Therapy And Eye Health

GLP-1 therapies have transformed obesity and diabetes treatment, but reports linking semaglutide to NAION have raised understandable concerns. While the condition deserves attention, current evidence suggests that the absolute risk remains very low. Understanding who is at higher risk, what symptoms matter most, and how vascular health influences the optic nerve helps place this rare complication into proper perspective while preserving the broader benefits of treatment.